Abstract
KW-1070, a new antibiotic aminoglycoside developed in Japan, was given to 2 patients with acute cystitis, 3 with acute pyelonephritis and 1 with pneumonia.
The daily dosage was 400 mg. The duration of administration ranged from 7.5 days to 12.5 days.
The efficacy rate was 100 percent.
Thrombocytepenia was detected in 1 patient, and an elevation in both serum GOT level and serum GPT level was detected in 1 patient. However, these side effects were all reversible, and no other side effects were observed.
